Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

927 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pathophysiology of bone disease in chronic kidney disease: from basics to renal osteodystrophy and osteoporosis.
Aguilar A, Gifre L, Ureña-Torres P, Carrillo-López N, Rodriguez-García M, Massó E, da Silva I, López-Báez V, Sánchez-Bayá M, Prior-Español Á, Urrutia M, Paul J, Bustos MC, Vila A, Garnica-León I, Navarro-González JF, Mateo L, Bover J. Aguilar A, et al. Among authors: da silva i. Front Physiol. 2023 Jun 5;14:1177829. doi: 10.3389/fphys.2023.1177829. eCollection 2023. Front Physiol. 2023. PMID: 37342799 Free PMC article. Review.
Integral pharmacological management of bone mineral disorders in chronic kidney disease (part II): from treatment of phosphate imbalance to control of PTH and prevention of progression of cardiovascular calcification.
Bover J, Ureña-Torres P, Lloret MJ, Ruiz C, DaSilva I, Diaz-Encarnacion MM, Mercado C, Mateu S, Fernández E, Ballarin J. Bover J, et al. Expert Opin Pharmacother. 2016 Jul;17(10):1363-73. doi: 10.1080/14656566.2016.1182985. Epub 2016 May 17. Expert Opin Pharmacother. 2016. PMID: 27156578 Review.
Integral pharmacological management of bone mineral disorders in chronic kidney disease (part I): from treatment of phosphate imbalance to control of PTH and prevention of progression of cardiovascular calcification.
Bover J, Ureña-Torres P, Lloret MJ, Ruiz-García C, DaSilva I, Diaz-Encarnacion MM, Mercado C, Mateu S, Fernández E, Ballarin J. Bover J, et al. Expert Opin Pharmacother. 2016 Jun;17(9):1247-58. doi: 10.1080/14656566.2016.1182155. Epub 2016 May 13. Expert Opin Pharmacother. 2016. PMID: 27156993 Review.
927 results